Selectquote, Inc. (SLQT)
NYSEFinancialsInsurance BrokersSnapshot 2026-07-23
Reading SLQT? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →NYSEFinancialsInsurance BrokersSnapshot 2026-07-23
Reading SLQT? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a turnaround story in the financial sector. The current thesis state indicates that SLQT is facing weak recent performance but is positioned within a sector that may provide tailwinds.
The market seems to have priced in a cheap valuation compared to peers, with expectations indicating a gap that suggests low confidence in execution quality. This reflects a justified valuation given the current fragility of earnings quality.
Management is behind on revenue guidance, with recent financial performance showing limited progress. However, there has been a significant improvement in operating cash flow, indicating some positive momentum.
The thesis hinges on management's ability to meet revenue and EBITDA targets, as well as external factors like interest rate movements and performance from sector leaders. A cut in guidance or unfavorable economic conditions could negatively impact SLQT.
Over the next 1 to 3 years, SLQT's performance will depend on its execution and broader sector trends. Not investment advice.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-07-23
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: Earnings results will provide insight into financial health and future guidance. This is crucial for assessing the company's direction.
Confirms one read:The earnings report shows a big profit increase from past quarters.
Confirms the other:The earnings report shows a profit drop or does not meet analyst expectations.
Why it matters: Meeting revenue guidance is crucial for investor confidence and growth outlook. It shows the company is on track.
Confirms:Q3 revenue reported at least $1.61 billion.
Disproves:Q3 revenue reported below $1.61 billion.
Why it matters: This earnings report will provide key updates on revenue and EBITDA guidance.
Confirms one read:Earnings report shows revenue and EBITDA meeting or beating guidance.
Confirms the other:Earnings report shows revenue and EBITDA below guidance.
Why it matters: Meeting or exceeding this revenue target shows progress toward the annual goal of $1.61B to $1.71B.
Confirms:Q3 revenue reported at or above $430 million.
Disproves:Q3 revenue falls below $430 million.
Why it matters: The FOMC's choice can change interest rates and how much people spend. This affects Selectquote's market.
Confirms one read:The FOMC raises interest rates. This shows a tighter monetary policy.
Confirms the other:The FOMC keeps interest rates the same or lowers them. This shows a more relaxed policy.
Why it matters: A drop below 15% would signal a slowdown in the sector's growth phase. This could hurt investor confidence.
Confirms:Q2 revenue growth reported below 15% year over year.
Disproves:Q2 revenue growth remains at or above 15% year over year.
Why it matters: Keeping cash flow above this level shows strong finances and good operations.
Confirms:Operating cash flow reported at or above $25 million.
Disproves:Operating cash flow falls below $25 million.
Why it matters: If guidance of $90M to $100M is confirmed, it shows stable earnings.
Confirms:Adjusted EBITDA is at least $90 million.
Disproves:Adjusted EBITDA is less than $90 million.
Why it matters: More SelectRx members show a strong need for healthcare services.
Confirms:SelectRx members grow by more than 11% year-over-year.
Disproves:SelectRx members grow by less than 11% year-over-year.
Why it matters: This range shows the company is better at managing cash flow.
Confirms:Operating cash flow was between $25 million and $35 million.
Disproves:Operating cash flow falls below $25 million.